Table 4. Hemorrhage assessment in immunocompetent C57BL/6 mice of DEN-4 2A E gene single amino acid mutant viruses.
Virus Strain | SubstitutionMutationViruses | Mouse No. | Severity of Hemorrhage | % of Hemorrhage Development | |
Skin | Subcutaneous | ||||
DEN-4 2A | Wild type | 1-1 | + | − | 20% |
1-2 | − | − | |||
1-3 | − | − | |||
1-4 | − | − | |||
1-5 | − | − | |||
E-T138P | 2-1 | ++ | − | 40% | |
2-2 | + | − | |||
2-3 | − | − | |||
2-4 | − | − | |||
2-5 | − | − | |||
E-G328S | 3-1 | − | − | 20% | |
3-2 | − | − | |||
3-3 | − | − | |||
3-4 | − | − | |||
3-5 | + | − | |||
E-Q438H | 4-1 | − | − | 60% | |
4-2 | − | + | |||
4-3 | − | − | |||
4-4 | + | + | |||
4-5 | ++ | − | |||
E-V463L | 5-1 | − | − | 80% | |
5-2 | +++ | − | |||
5-3 | + | + | |||
5-4 | + | − | |||
5-5 | ++ | − |
Rates represent hemorrhage percentage in each independent experiment. A three-level bleeding scoring low (“+”), medium (“++”), high (“+++”), and no bleeding (“−“) was used to indicate the severity of hemorrhaging between different experimental cases.